XML 85 R57.htm IDEA: XBRL DOCUMENT v3.25.4
Share-based compensation - Plans (Details) - $ / shares
1 Months Ended 12 Months Ended
Jan. 01, 2026
Jan. 01, 2025
Jun. 28, 2023
Sep. 30, 2020
Aug. 31, 2020
Dec. 31, 2025
May 31, 2025
Dec. 31, 2024
Oct. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Shares available for future issuance           19,861,949   15,528,401  
Options, Granted           5,562,784      
Granted           $ 10.36      
Dr. Clay Siegall | Morphimmune Inc                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Options, Granted     2,137,080            
2020 Plan                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Threshold Percentage Of Total Number Of Common Stock Outstanding         4.00%        
Shares available for future issuance           644,655      
Expiration period           10 years      
2020 Plan | Subsequent events                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Increase in shares available for future issuance 4,525,327                
2020 Plan | Maximum                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Vesting period           4 years      
2020 Plan | Minimum                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Vesting period           1 year      
2024 Inducement Plan                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Shares available for future issuance                 2,000,000
Shares available for grant           1,251,300      
2024 Inducement Plan | Maximum                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Shares available for future issuance             3,500,000    
2024 Inducement Plan | Minimum                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Shares available for future issuance             2,000,000    
MorphImmune Plan                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Shares available for future issuance           558,377      
Employee Stock Purchase Plan                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Increase in shares available for future issuance   1,000,000              
Authorized stock options           125,000      
Employee Stock Purchase Plan, Threshold Period For Which Common Stock Is Automatically Added To Arrive At Authorized Shares           10 years      
Percentage of outstanding capital stock           1.00%      
Purchase price percentage       85.00%          
Maximum number of shares that can be purchased       15.00%          
Number of common shares added in authorized           1,000,000      
Shares available for grant           1,550,859   906,251  
Awards granted           0